T cells in coeliac disease: a rational target for diagnosis and therapy

Melinda Y Hardy^{1

2}, Jason A Tye-Din^{3

4

5}

Affiliations

¹ Immunology Division, The Walter and Eliza Hall Institute, Parkville, Victoria, Australia.
² Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.
³ Immunology Division, The Walter and Eliza Hall Institute, Parkville, Victoria, Australia. tyedin@wehi.edu.au.
⁴ Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia. tyedin@wehi.edu.au.
⁵ Department of Gastroenterology, The Royal Melbourne Hospital, Parkville, Victoria, Australia. tyedin@wehi.edu.au.

Comment

Melinda Y Hardy et al. Nat Rev Gastroenterol Hepatol. 2018 Oct.

. 2018 Oct;15(10):583-584.

doi: 10.1038/s41575-018-0043-4.

Melinda Y Hardy^{1

2}, Jason A Tye-Din^{3

4

5}

¹ Immunology Division, The Walter and Eliza Hall Institute, Parkville, Victoria, Australia.
² Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.
³ Immunology Division, The Walter and Eliza Hall Institute, Parkville, Victoria, Australia. tyedin@wehi.edu.au.
⁴ Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia. tyedin@wehi.edu.au.
⁵ Department of Gastroenterology, The Royal Melbourne Hospital, Parkville, Victoria, Australia. tyedin@wehi.edu.au.

No abstract available

Comment on

Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease.
Risnes LF, Christophersen A, Dahal-Koirala S, Neumann RS, Sandve GK, Sarna VK, Lundin KE, Qiao SW, Sollid LM. Risnes LF, et al. J Clin Invest. 2018 Jun 1;128(6):2642-2650. doi: 10.1172/JCI98819. Epub 2018 May 14. J Clin Invest. 2018. PMID: 29757191 Free PMC article.